Susceptibility of multiply antibiotic-resistant pneumococci to the new quinoline antibiotics, nalidixic acid, coumermycin, and novobiocin
- PMID: 6570085
- PMCID: PMC180054
- DOI: 10.1128/AAC.26.6.933
Susceptibility of multiply antibiotic-resistant pneumococci to the new quinoline antibiotics, nalidixic acid, coumermycin, and novobiocin
Abstract
The susceptibility of 10 multiply antibiotic-resistant strains of Streptococcus pneumoniae to several quinoline antibiotics and to coumermycin, novobiocin, and penicillin was determined. The MIC of penicillin for all test isolates was greater than or equal to 4 micrograms/ml. Ciprofloxacin was the most active quinoline derivative tested, followed by norfloxacin. These isolates of S. pneumoniae were not inhibited by the remaining quinolines at achievable concentrations in serum. Coumermycin and ciprofloxacin were the most active antibiotics tested in this study.
Similar articles
-
World-wide development of antibiotic resistance in pneumococci.Eur J Clin Microbiol. 1987 Aug;6(4):367-77. doi: 10.1007/BF02013089. Eur J Clin Microbiol. 1987. PMID: 3311732 Review.
-
Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations.Antimicrob Agents Chemother. 1985 Nov;28(5):634-8. doi: 10.1128/AAC.28.5.634. Antimicrob Agents Chemother. 1985. PMID: 2936300 Free PMC article.
-
Studies on mutational cross-resistance between ciprofloxacin, novobiocin and coumermycin in Escherichia coli and Staphylococcus warneri.Microbios. 1993;75(304):185-95. Microbios. 1993. PMID: 8246811
-
In vitro activity of coumermycin A1.Appl Microbiol. 1969 Nov;18(5):869-73. doi: 10.1128/am.18.5.869-873.1969. Appl Microbiol. 1969. PMID: 4391844 Free PMC article.
-
The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.Dan Med Bull. 2000 Nov;47(5):313-27. Dan Med Bull. 2000. PMID: 11155659 Review.
Cited by
-
Fluoroquinolone antimicrobial agents.Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378. Clin Microbiol Rev. 1989. PMID: 2680058 Free PMC article. Review.
-
In vitro activity of ciprofloxacin combined with azlocillin.Antimicrob Agents Chemother. 1985 Dec;28(6):849-50. doi: 10.1128/AAC.28.6.849. Antimicrob Agents Chemother. 1985. PMID: 2935078 Free PMC article.
-
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003. Drugs. 1988. PMID: 3292209 Review.
-
World-wide development of antibiotic resistance in pneumococci.Eur J Clin Microbiol. 1987 Aug;6(4):367-77. doi: 10.1007/BF02013089. Eur J Clin Microbiol. 1987. PMID: 3311732 Review.
-
Pneumococcal resistance to antibiotics.Clin Microbiol Rev. 1990 Apr;3(2):171-96. doi: 10.1128/CMR.3.2.171. Clin Microbiol Rev. 1990. PMID: 2187594 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical